Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Company price
0.0005 USD 0.00(0%)
Last update at 2026-11-20T20:00:00Z
VOLUME
999820
Market Cap
0.65M

Momentum Score

…

CYIOS Corporation operates as a holding company that engages in building, acquiring, and operating businesses across medical supplies, technology, and fintech industries. The company, through its subsidiary, delivers products to healthcare providers. CYIOS Corporation was founded in 1997 and is based in Deerfield Beach, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.00
Low
0.00
High
52 Week Price Range
0.00
Low
0.01
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Publicly available information on CYIOS Corporation (ticker CYIO on the Pink Sheets) is limited; the company is an OTC-listed small-cap with minimal current disclosure and its precise core business and operations are not well documented. Long-term growth depends on clarifying the business model, securing financing or strategic partners and executing any stated plans; investors may find potential upside if transparency and operational traction improve.

Key risks include limited disclosure and liquidity, substantial financing needs, execution and governance uncertainty, and heightened risk of regulatory action or delisting.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.00
Dividend Yield
-
Revenue TTM
1.49M
Revenue Per Share
0.04
Gross Profit TTM
0.65M
Debt / Equity
-1.17
ROE
-17.91%
Net Debt
2.33M
ROCE
9.53%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -1.31M -0.27M -2.38M -2.89M -0.74M
Net income -1.31M -0.36M -2.38M -2.89M -0.74M
Gross profit 0.53M 0.04M 0.06M -0.03M 0.01M
Ebit - 0.13M -1.55M -1.12M -0.72M
Ebitda -0.91M 0.13M -1.32M -1.12M -0.52M
Depreciation and amortization - 0.00M 0.23M 0.00M 0.21M
Operating income -0.19M -0.46M -1.08M -1.20M -0.72M
Other operating expenses 8.21M 0.49M 1.18M 1.94M 0.76M
Interest expense 0.40M 0.40M 0.83M 1.77M 0.01M
Income tax expense - -0.00M -0.23M 0.00M -0.21M
Total revenue 8.02M 0.04M 0.10M 0.74M 0.04M
Total operating expenses 0.73M 0.49M 1.14M 1.16M 0.74M
Cost of revenue 7.49M 0.00M 0.04M 0.78M 0.03M
Total other income expense net -1.11M 0.09M -1.30M -1.69M -0.01M
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 0.96M 1.02M 1.05M 1.57M 0.06M
Other current assets 0.07M 0.03M 0.07M 0.11M -
Total liab 2.99M 2.53M 2.51M 1.68M 0.59M
Total stockholder equity -2.03M -1.51M -1.46M -0.11M -0.53M
Other current liab -0.00M 0.00M 0.01M 0.01M -
Common stock 0.28M 0.24M 0.15M 0.12M 0.09M
Retained earnings -32.44M -31.23M -30.86M -28.48M -25.60M
Good will 0.25M 0.93M 0.93M 0.68M -
Other assets - 0.00M - - -
Cash 0.03M 0.01M 0.00M 0.34M 0.04M
Total current liabilities 2.99M 2.53M 2.51M 1.68M 0.18M
Current deferred revenue - - - 0.00M -
Net debt 2.33M 2.01M 2.09M 1.26M 0.37M
Short term debt 2.36M 2.02M 2.09M 1.60M 0.00M
Short long term debt total 2.36M 2.02M 2.09M 1.60M 0.41M
Other stockholder equity 29.91M 29.47M 28.56M 27.32M 24.79M
Total current assets 0.61M 0.05M 0.08M 0.46M 0.06M
Net receivables 0.43M - - 0.00M -
Inventory 0.09M 0.01M 0.01M 0.01M 0.02M
Accounts payable 0.62M 0.51M 0.41M 0.07M 0.18M
Accumulated other comprehensive income 0.23M 0.01M 0.68M 0.91M 0.19M
Non currrent assets other - -0.00M - 0.38M -
Non current assets total 0.35M 0.97M 0.97M 1.11M -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total cashflows from investing activities - 0.00M 0.01M -0.15M 0.01M
Total cash from financing activities 0.32M 0.07M 0.50M 1.37M 0.60M
Net income -1.31M -0.27M -2.38M -0.34M -0.74M
Change in cash 0.02M 0.01M -0.34M 0.30M 0.04M
Begin period cash flow 0.01M 0.00M 0.34M 0.04M -
End period cash flow 0.03M 0.01M 0.00M 0.34M 0.04M
Total cash from operating activities -0.30M -0.06M -0.85M -0.92M -0.58M
Depreciation - 0.00M - 0.00M -
Other cashflows from investing activities - -0.00M - -0.10M 0.01M
Change to inventory -0.03M - - 0.01M -0.02M
Change to account receivables 0.23M - 0.00M -0.00M -
Other cashflows from financing activities - 0.07M 0.50M 0.00M 0.19M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M
Change in working capital 0.17M 0.14M 0.38M -0.20M 0.16M
Other non cash items 0.84M 0.07M 1.16M -0.38M -0.16M
Free cash flow -0.30M -0.06M -0.85M -0.92M -0.58M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CYIO
CYIOS Corporation
-
-%
0.00 - - 0.39 1.52 1.76 -45.74
HCA
HCA Healthcare, Inc.
15.19
3.30%
475.52 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation
-0.10
0.04%
263.49 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR
-0.22
1.52%
14.00 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
1.31
30.75%
5.57 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

CYIOS Corporation

CYIOS Corporation operates as a holding company that engages in building, acquiring, and operating businesses across medical supplies, technology, and fintech industries. The company, through its subsidiary, delivers products to healthcare providers. CYIOS Corporation was founded in 1997 and is based in Deerfield Beach, Florida.

258 South Military Trail, Deerfield Beach, FL, United States, 33442

888 285 1351

15

Name Title Year Born
Mr. David Lewis CEO & Director NA
Mr. Franco Devivo VP Marketing & Bus. Devel. NA
Mr. John Fredrick O'Shea CEO & Chairman of the Board 1968
Mr. Jonathan D. Leinwand Esq. Legal council 1970

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…